P&PAULSON & CO. INC.
Institutional investor · Portfolio as of Q4 2023
Top Holdings17 positions
MADRIGAL PHARMACEUTICALS INC | 1.1M | $255.8M | 23.1% | $219.70 | +5.32% | 3 qtrssince 2023-Q2 | Increased 99 |
BAUSCH HEALTH COS INC | 26.4M | $212M | 19.1% | $20.74 | -61.32% | 17 qtrssince 2019-Q3 | Unchanged 0 |
BRIGHTSPHERE INVT GROUP INC | 9M | $171.5M | 15.5% | $9.52 | +99.80% | 17 qtrssince 2019-Q3 | Unchanged 0 |
NOVAGOLD RES INC | 23.5M | $88M | 7.9% | $6.35 | -41.11% | 17 qtrssince 2019-Q3 | Increased 64 |
PERPETUA RESOURCES CORP | 24.8M | $78.5M | 7.1% | $5.97 | -46.86% | 11 qtrssince 2021-Q1 | Unchanged 0 |
ANGLOGOLD ASHANTI PLC | 3.8M | $71.6M | 6.5% | $14.17 | +18.29% | 2 qtrssince 2023-Q3 | Unchanged 0 |
AGNICO EAGLE MINES LTD | 783,561 | $43M | 3.9% | $55.39 | -5.14% | 8 qtrssince 2022-Q1 | Unchanged 0 |
THRYV HLDGS INC | 2M | $40.7M | 3.7% | $13.03 | +56.18% | 12 qtrssince 2020-Q4 | Unchanged 0 |
INTERNATIONAL TOWER HILL MIN | 61.9M | $36.2M | 3.3% | $0.55 | +6.94% | 17 qtrssince 2019-Q3 | Unchanged 0 |
NEWMARK GROUP INC | 3M | $32.9M | 3.0% | $9.45 | +12.81% | 17 qtrssince 2019-Q3 | Increased 83 |
SEABRIDGE GOLD INC | 2.1M | $25.1M | 2.3% | $17.03 | -28.75% | 17 qtrssince 2019-Q3 | Unchanged 0 |
SSR MINING IN | 2M | $21.5M | 1.9% | $15.89 | -71.95% | 17 qtrssince 2019-Q3 | Unchanged 0 |
EQUINOX GOLD CORP | 2.5M | $12.2M | 1.1% | $11.17 | -56.42% | 14 qtrssince 2020-Q2 | Unchanged 0 |
TRILOGY METALS INC NEW | 14.3M | $6.2M | 0.6% | $1.67 | -74.25% | 17 qtrssince 2019-Q3 | Unchanged 0 |
IAMGOLD CORP | 1.9M | $4.7M | 0.4% | $3.41 | -25.81% | 17 qtrssince 2019-Q3 | Unchanged 0 |
TELLURIAN INC NEW | 5.3M | $4M | 0.4% | — | — | 9 qtrssince 2021-Q4 | Unchanged 0 |
ALIBABA GROUP HLDG LTD | 50,000 | $3.9M | 0.3% | $115.53 | -36.02% | 10 qtrssince 2021-Q3 | Unchanged 0 |
PAULSON & CO. INC. manages $1.1B across 17 positions as of Q4 2023. Top holdings: MDGL (23.1%), BHC (19.1%), AAMI (15.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Exited 1, increased 3. Top move: MDGL (INCREASED, conviction 99). Portfolio: $1.1B across 17 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR